Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Safety, PKs, PDs, and Preliminary Efficacy PLX2853 Subjects w/Relap or Refrac AML or Myelodysplastic

Protocol: OSU-18314

Full Title

A Phase 1b Dose-escalation Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of PLX2853 in Subjects with Relapsed or Refractory Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome

Phase I Study

Principal Investigator

Alice Mims

Alice Mims

For More Information

See Full Trial at ClinicalTrials.gov
Email This Trial to Your Physician to Verify Eligibility
Print a Copy of This Trial
Learn More About Clinical Trial Phases
Protocol Page
Leukemia Acute Myeloid Leukemia Myelodysplastic Syndrome